(Q38054223)

English

HDAC inhibitor modulation of proteotoxicity as a therapeutic approach in cancer

scientific article published on January 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23088870

retrieved

27 August 2017

title

HDAC inhibitor modulation of proteotoxicity as a therapeutic approach in cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27 August 2017

David J McConkey

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23088870

retrieved

27 August 2017

Matthew White

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23088870

retrieved

27 August 2017

Wudan Yan

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23088870

retrieved

27 August 2017

publication date

1 January 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23088870

retrieved

27 August 2017

published in

Advances in Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23088870

retrieved

27 August 2017

volume

116

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23088870

retrieved

27 August 2017

page(s)

131-163

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23088870

retrieved

27 August 2017

cites work

Regulated translation initiation controls stress-induced gene expression in mammalian cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S1097-2765(00)00108-8

Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/1535-7163.MCT-10-1108

The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1182/BLOOD-2009-12-257261

Identifiers

DOI

10.1016/B978-0-12-394387-3.00004-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23088870

retrieved

27 August 2017

PubMed publication ID

23088870

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23088870

retrieved

27 August 2017

(Q38054223)

HDAC inhibitor modulation of proteotoxicity as a therapeutic approach in cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)